FDA approves Abbott's new 'minimally invasive' pacemaker
The North Chicago-based drug giant received approval for a "new minimally invasive" pacemaker that it says will revolutionize treatment of a variety of slow…
Stay updated with breaking news from North Chicago Based. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The North Chicago-based drug giant received approval for a "new minimally invasive" pacemaker that it says will revolutionize treatment of a variety of slow…
Oak Street CEO talks about using CVS's arsenal for growth, a study says surgery may drastically improve childhood epilepsy survival and more in today's Health Pulse.
Ironwood Pharmaceuticals is paying $1 billion to acquire VectivBio, a biotech whose lead program could become a blockbuster treatment for a gastrointestinal disorder. Preliminary Phase 3 data are expected by the end of 2023.
Crain's Health Pulse is your source for actionable, exclusive and inside news on the health care industry.
Belts tightened across corporate America in 2022, and Chicago’s $20 million club — the ledger of CEOs paid that amount or more — was no exception.